Teva To Acquire Theramex in €265M Deal

Law360, New York (October 28, 2010, 1:05 PM EDT) -- Teva Pharmaceutical Industries Ltd. has reached an agreement to acquire Theramex, Merck KGaA's European women's health business, for €265 million ($369 million) cash in a bid to boost its own women's health franchise.

Under the terms of the transaction announced Thursday, Teva will pay €265 million to Merck KGaA's Merck Serono SA unit when the deal closes. In addition, Merck Serono will be eligible to receive performance-based milestone payments, the details of which were not disclosed.

The agreement also will give Teva distribution rights for Theramex...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.